公司资料

Veradigm 股价、新闻与催化剂

股票代码:: MDRX
交易所:: NASDAQ
行业:: Biopharma
所在地:: United States

股票表现

5.00 USD (-2.72%)

收盘价

最后更新: 2026年10月1日

—

市值

股价为何变动

截至 2026年10月1日，MDRX 下跌 2.72%，收于 $5.00。当前新闻监测窗口内未发现新的同公司新闻。

公司概览

业务概览

Veradigm is a healthcare information and analytics company focused on software, data, and workflow tools for providers and life-sciences customers. Its business is more about information infrastructure than therapeutic innovation.

所在地与行业分类

Headquartered in the United States and listed on NASDAQ, Veradigm sits in healthcare IT.

商业模式特征

Revenue depends on software subscriptions, data products, and the commercialization of workflow tools across healthcare users.

生物医药行业定位

Veradigm is outside biotech and belongs to the healthcare information layer, where software adoption and execution matter most.

未来催化剂

Veradigm's catalysts are claims-data products, payer and life-science software demand, and any operating update that clarifies the turnaround path. The company is still a software-and-data execution story.